Only about one in four people with hypertension has blood pressure well-controlled and the numbers are similar for those with dyslipidemia, which is why a one-pill solution -- the polypill -- appeals to many.
MD, DPhil, is arguably the most enthusiastic and eloquent of polypill believers, which is why 51˶ reached out to Yusuf for comment on the most recent polypill study and to speculate on the future of fixed-dose solutions.